CGH-1110 analogs (Novartis)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug NameCGH-1110 analogs (Novartis)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFactor IIa inhibitorsTrypsin inhibitors
TargetsProthrombinTrypsin
Therapy Area/IndicationsVenous ThrombosisMyocardial InfarctionStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Ag
Active IndicationsN/A
Inactive IndicationsVenous ThrombosisMyocardial InfarctionStroke

Other Information

ATC CodeN/A
Related LinksN/A